Source: GlobalNewswire

Press Release: Sigilon : BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE - AEL), Amedisys, Inc. (Nasdaq - AMED), Sigilon Therapeutics, Inc (Nasdaq - SGTX)

BALA CYNWYD, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
Rogerio Vivaldi's photo - President & CEO of Sigilon

President & CEO

Rogerio Vivaldi

CEO Approval Rating

89/100

Read more